Ruirui Gui

Reduced‐dose post‐transplant cyclophosphamide plus low‐dose post‐transplant anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis with fludarabine–busulfan–cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial

Wenli Zhang, Ruirui Gui, Yingling Zu et al. · British Journal of Haematology · 2022 · 41 citations

Medicine, Hematology, Immunology +17

Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia

Keshu Zhou, Wentao Zhang, Qing Zhang et al. · Oncotarget · 2017 · 25 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis

Binglei Zhang, Jian Zhou, Ruirui Gui et al. · Frontiers in Cellular and Infection Microbiology · 2021 · 25 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +13

Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial

Yingling Zu, Zhen Li, Ruirui Gui et al. · Bone Marrow Transplantation · 2022 · 21 citations · Full text

Medicine, Hematology, Immunology +13

Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia

Binglei Zhang, Lingyun Chen, Jian Zhou et al. · Scientific Reports · 2021 · 17 citations · Full text

Medicine, Hematology, Immunology +14